The Effect of Androgen Deprivation Therapy on Periodontal Disease in Men With Prostate Cancer

Journal of Urology

Volumn 177, Issue 3, 2007, Pages 921-924

  Famili, Pouran ^a   Cauley, Jane A ^b   Greenspan, Susan L ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

androgen antagonists; osteoporosis; periodontal diseases; prostate; prostatic neoplasms

Indexed keywords

ANDROGEN;

ADULT; AGED; ANDROGEN DEFICIENCY; ARTICLE; BLEEDING; BONE DENSITY; CANCER RESEARCH; CONFIDENCE INTERVAL; CONTROLLED STUDY; GINGIVA DISEASE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OSTEOPOROSIS; PERIODONTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING; TOOTH PLAQUE;

AGED; ANDROGEN ANTAGONISTS; BONE DENSITY; CASE-CONTROL STUDIES; HUMANS; MALE; PERIODONTAL DISEASES; PREVALENCE; PROSTATIC NEOPLASMS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 33846889038     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.10.067     Document Type: Article

References (19)

1. Ross R.W., and Small E.J. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. J Urol 167 (2002) 1952
2. Wei J.T., Gross M., Jaffe C.A., Gravlin K., Lahie M., Faerber G.J., et al. Androgen deprivation therapy for prostate cancer results in significant loss of bone density. Urology 54 (1999) 607
3. Diamond T., Campbell J., Bryant C., and Lynch W. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer 83 (1998) 1561
4. Morote J., Martinez E., Trilla E., Esquena S., Abascal J.M., Encabo G., et al. Osteoporosis during continuous androgen deprivation: Influence of the modality and length of treatment. Eur Urol 44 (2003) 661
5. Deng J.H., Yang L.P., Wang L.S., and Zhou D.F. Effect of androgen-deprivation therapy on bone mineral density in prostate cancer patients. Asian J Androl 6 (2004) 75
6. Higano C.S. Management of bone loss in men with prostate cancer. J Urol, part 2 170 (2003) S59
7. Seeman E. Osteoporosis in men. Baillieres Clin Rheumatol 11 (1997) 613
8. Seeman E., and Eisman J.A. Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture. Med J Aust 180 (2004) 298
9. Seeman E., Melton III L.J., O'Fallon W.M., and Riggs B.L. Risk factors for spinal osteoporosis in men. Am J Med 75 (1983) 977
10. Rees T.D. A profile of the patient with periodontal disease?. Periodontol 2000 32 (2003) 9
11. Albandar J.M., and Ram T.E. Global epidemiology of periodontal diseases: an overview. Periodontol 2000 29 (2002) 7
12. Slots J. Update of general health risk of periodontal disease. Int Dental J 3 suppl. (2003) 200
13. Nunn M.E. Understanding the etiology of periodontitis: an overview of periodontal risk factors. Periodontol 2000 32 (2003) 11
14. Genco R.J. Current view of risk factors for periodontal disease. J Periodontol 67 (1996) 1041
15. Weyant R.J., Pearlstein M.E., Churak A.P., Forrest K., Famili P., and Cauley J.A. The association between osteopenia and periodontal attachment loss in older women. J Periodontol 70 (1999) 982
16. Eggert F.M., McLeod M.H., and Flowerdew G. Effects of smoking and treatment status on periodontal bacteria: Evidence that smoking influences control of periodontal bacteria at the mucosal surface of the gingival crevice. J Periodontol 72 (2001) 1210
17. Rashid M.H., and Chaudhary U.B. Intermittent androgen deprivation therapy for prostate cancer. Oncologist 9 (2004) 295
18. Jeffcoat M.K. Osteoporosis: a possible modifying factor in oral bone loss. Ann Periodontol 3 (1998) 312
19. Kribbs P.J. Comparison of mandibular bone in normal and osteoporotic women. J Prosthet Dentistry 63 (1990) 218